FCM

Farallon Capital Management Portfolio holdings

AUM $15.3B
1-Year Est. Return 51.42%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+51.42%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.3B
AUM Growth
-$2.87B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
201
New
Increased
Reduced
Closed

Top Buys

1
+$292M
2
+$280M
3
+$248M
4
MA icon
Mastercard
MA
+$138M
5
TMO icon
Thermo Fisher Scientific
TMO
+$133M

Top Sells

1
+$650M
2
+$470M
3
+$334M
4
NDAQ icon
Nasdaq
NDAQ
+$290M
5
RNAM
Avidity Biosciences
RNAM
+$233M

Sector Composition

1 Healthcare 57.82%
2 Financials 13.96%
3 Technology 12.78%
4 Consumer Discretionary 5.83%
5 Industrials 4.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDU icon
176
New Oriental
EDU
$7.41B
– –
-196,000
ESTA icon
177
Establishment Labs
ESTA
$2.13B
– –
-3,000
EXAS
178
DELISTED
Exact Sciences
EXAS
– –
-6,405,000
GPCR icon
179
Structure Therapeutics
GPCR
$2.67B
– –
-454,000
HYG icon
180
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.8B
– –
0
IBIT icon
181
iShares Bitcoin Trust
IBIT
$51.9B
– –
-2,137,100
ICLR icon
182
Icon
ICLR
$11B
– –
-1,200
INSM icon
183
Insmed
INSM
$22.5B
– –
-3,000
LLY icon
184
Eli Lilly
LLY
$962B
– –
0
MLYS icon
185
Mineralys Therapeutics
MLYS
$2.07B
– –
-823,296
NDAQ icon
186
Nasdaq
NDAQ
$49.1B
– –
-2,989,213
NYT icon
187
New York Times
NYT
$12.2B
– –
-3,280,678
PPA icon
188
Invesco Aerospace & Defense ETF
PPA
$8.02B
– –
0
RNAM
189
DELISTED
Avidity Biosciences
RNAM
– –
-3,233,000
RSP icon
190
Invesco S&P 500 Equal Weight ETF
RSP
$89.5B
– –
0
SLNO
191
DELISTED
Soleno Therapeutics
SLNO
– –
-5,000
SPY icon
192
State Street SPDR S&P 500 ETF Trust
SPY
$781B
– –
0
TRU icon
193
TransUnion
TRU
$13.4B
– –
-675,000
VSTM icon
194
Verastem
VSTM
$318M
– –
-2,000,000
DAY
195
DELISTED
Dayforce
DAY
– –
-2,925,000
ETH
196
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.64B
– –
-228,340
ETHA
197
iShares Ethereum Trust ETF
ETHA
$5.36B
– –
-1,481,001
SUNC
198
SunocoCorp LLC
SUNC
$3.45B
– –
-606,277
MDLN
199
Medline Inc
MDLN
$29.1B
– –
-260,000
4 5 6 7
8